Trials / Completed
CompletedNCT02598544
Endocrine Regulation of Lipolysis in Obesity and Diabetes
Atrial Natriuretic Peptide (ANP)-Induced Lipid Mobilization Regulation in Different Adipose Tissue Depots of Obese Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Hasselt University · Academic / Other
- Sex
- Male
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Adipose tissue (AT) dysfunction is a commonly observed feature of metabolic dysfunction in obesity and diabetes. An important characteristic when examining AT function is the capacity to break down stored lipids (i.e. lipolysis) and its regulation. In the present study, the aim was to investigate whether atrial natriuretic peptide-mediated lipolysis is altered in different adipose tissue depots (subcutaneous and visceral adipose tissue) of obese subjects with or without type 2 diabetes, compared to age-matched lean men. Eventually, the knowledge gained from this research will contribute to a better understanding of the present adipose tissue dysfunction and to the optimization of exercise programs for people with obesity and diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | adipose tissue sampling | adipose tissue (subcutaneous and visceral adipose tissue) sampling during abdominal surgery and phenotype determination |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2015-11-06
- Last updated
- 2016-11-18
Locations
4 sites across 2 countries: Belgium, Netherlands
Source: ClinicalTrials.gov record NCT02598544. Inclusion in this directory is not an endorsement.